← Leaderboards
Qin Feng
Baylor College Of Medicine
$4,235,805
Attributed
$4,235,805
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $884.2K · FY2007–21$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,235,805 · 6
By mechanism
R33$2,172,684 · 2
R61$1,177,546 · 1
R21$435,875 · 1
K01$352,707 · 1
F32$96,993 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Bert W O'Malley$52,747,816
- David D Moore$17,888,087
- Orla M. Conneely$6,697,579
- Biao Zheng$3,487,743
- Zhao Wang$4,579,036
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsComplexGene ExpressionGenetic TranscriptionBaseMemory Cd4 T LymphocytePurgeReaderHiv InfectionsCoactivator-Associated Arginine Methyltransferase 1Inhibitor/AntagonistInfectionLifeMediatingProductionEpigenetic RegulationGenesEpigenetic ProcessPositive Transcriptional Elongation Factor BCell ModelAntiretroviral TherapyHiv-1ProvirusesRest
Grant awards (15)
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation$380,273
R33 · FY2021 · AI · contact PI
An epigenomic approach to reactivate latent HIV$458,687
R33 · FY2020 · AI · contact PI
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation$387,083
R33 · FY2020 · AI · contact PI
An epigenomic approach to reactivate latent HIV$459,706
R33 · FY2019 · AI · contact PI
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation$384,023
R61 · FY2019 · AI · contact PI
An epigenomic approach to reactivate latent HIV$486,935
R33 · FY2018 · AI · contact PI
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation$397,273
R61 · FY2018 · AI · contact PI
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation$396,250
R61 · FY2017 · AI · contact PI
An epigenomic approach to reactivate latent HIV$221,900
R21 · FY2017 · AI · contact PI
An epigenomic approach to reactivate latent HIV$213,975
R21 · FY2016 · AI · contact PI
CARM1 Function in Hepatic Lipid and Glucose Metabolism$127,094
K01 · FY2011 · DK · contact PI
CARM1 Function in Hepatic Lipid and Glucose Metabolism$113,952
K01 · FY2010 · DK · contact PI
CARM1 Function in Hepatic Lipid and Glucose Metabolism$111,661
K01 · FY2009 · DK · contact PI
Regulation of a dual functional nuclear receptor coactivator CARM1$52,898
F32 · FY2008 · DK · contact PI
Regulation of a dual functional nuclear receptor coactivator CARM1$44,095
F32 · FY2007 · DK · contact PI